TipRanks
Ovid Therapeutics Inc (DE:1OT)
FRANKFURT:1OT
Germany Market
1OT
Ovid Therapeutics
RESEARCH TOOLSreports

Ovid Therapeutics (1OT) Stock News & Sentiment

6 Followers
Ovid Therapeutics: Buy Rating on Advancing OV329 Seizure Pipeline and Strong Cash Runway Through 2029
Premium
Ratings
Ovid Therapeutics: Buy Rating on Advancing OV329 Seizure Pipeline and Strong Cash Runway Through 2029
3M ago
OVID
Reiterated Buy Rating on Ovid Therapeutics as Solid Pipeline Execution and Two-Year Cash Runway Support Unchanged $5 Price Target
Premium
Ratings
Reiterated Buy Rating on Ovid Therapeutics as Solid Pipeline Execution and Two-Year Cash Runway Support Unchanged $5 Price Target
3M ago
OVID
Ovid Therapeutics: Buy Rating Backed by De-Risked Balance Sheet and Differentiated Epilepsy Pipeline (OV329, OV4071)
Premium
Ratings
Ovid Therapeutics: Buy Rating Backed by De-Risked Balance Sheet and Differentiated Epilepsy Pipeline (OV329, OV4071)
3M ago
OVID
Ovid Therapeutics appoints Charles Carter as new CFO
Premium
Company Announcements
Ovid Therapeutics appoints Charles Carter as new CFO
4M ago
8K
OVID
Ovid Therapeutics Shareholders Back Board and Governance Proposals
Premium
Company Announcements
Ovid Therapeutics Shareholders Back Board and Governance Proposals
5M ago
8K
OVID
Ovid Therapeutics Expands Board, Appoints New Scientific Director
Premium
Company Announcements
Ovid Therapeutics Expands Board, Appoints New Scientific Director
5M ago
8K
OVID
Ovid Therapeutics: Advancing Seizure Pipeline and Neuropsychiatric Programs Support Buy Rating and Unchanged $4 Price Target
Premium
Ratings
Ovid Therapeutics: Advancing Seizure Pipeline and Neuropsychiatric Programs Support Buy Rating and Unchanged $4 Price Target
5M ago
OVID
More DE:1OT News >

1OT News on the Web

Ovid Therapeutics (OVID) Cashes In One Bet To Fund Its Next Two
Insider Monkey
Neutral
After-hours Gainers: HOWL Jumps 90%, MODD To Begin Pivot Pump Rollout, BIVI Awaits Long COVID Data
rttnews
Bullish
Ovid Therapeutics CFO Jeffrey Rona to step down, Charles Carter to succeed
TipRanks News
Bullish
Ovid Therapeutics appoints Charles Carter as new CFO
TipRanks News
Neutral
Ovid Therapeutics Inc Annual Shareholders Meeting Transcript
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Ovid Therapeutics (OVID) and Establishment Labs Holdings (ESTA)
TipRanks News
Bullish
Ovid Therapeutics: Advancing Seizure Pipeline and Neuropsychiatric Programs Support Buy Rating and Unchanged $4 Price Target
TipRanks News
Bullish
LifeSci Capital Sticks to Its Buy Rating for Ovid Therapeutics (OVID)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:1OT’s Media Buzz Sentiment?
Currently, no data Available
What is DE:1OT’s weekly average amount of articles?
In an average week, 2 articles about DE:1OT are published.
    What is DE:1OT’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    GKOSGlaukos
    CNCCentene
    ASNDAscendis Pharma
    GILDGilead Sciences
    MRKMerck & Company
    Showing the stocks with the most bullish news sentiment over the past week